Related Experiment Video

Updated: Jun 27, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?

Thierry Soussi1, Linn Hjortsberg

  • 1Department of Oncology-Pathology, Cancer Centre Karolinska (CCK), Karolinska Institute, SE-171 76 Stockholm, Sweden. thierry.soussi@ki.se

Trends in Molecular Medicine
|December 23, 2008
PubMed

Insights

Cancer-associated p53 protein accumulation depends on tumor genetics, not p53 itself. Targeting the MDM2-p53 interaction for cancer therapy may be more complex than anticipated.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • p53 missense mutations in human cancers often correlate with elevated p53 protein levels in tumors.
  • The accumulation of mutant p53 protein has been a subject of research regarding its role in cancer progression.

Purpose of the Study:

  • To investigate the factors contributing to the accumulation of mutant p53 protein in tumors.
  • To understand the relationship between endogenous genetic background, Mdm2, p16INK4a, and p53 protein levels.

Main Methods:

  • Utilized mouse models to study p53 protein accumulation.
  • Analyzed the impact of Mdm2 and p16INK4a genes on mutant p53 levels.
  • Observed tumor characteristics, including metastatic potential, in different genetic backgrounds.

Main Results:

  • Mutant p53 protein accumulation is dependent on the tumor's endogenous genetic background, specifically Mdm2 and p16INK4a.
  • Mice expressing mutant p53 without Mdm2 developed more aggressive metastatic tumors.
  • The accumulation is not an intrinsic property of the mutant p53 protein itself.

Conclusions:

  • The genetic context of a tumor significantly influences p53 protein levels.
  • The MDM2-p53 interaction, a potential therapeutic target, is modulated by other genetic factors.
  • Therapeutic strategies targeting the MDM2-p53 pathway in human cancers may require consideration of the tumor's genetic background.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.